Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

Amundi increased its stake in PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) by 0.9% in the fourth quarter, according to ...

A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be ...

PROCEPT BioRobotics SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing ...

SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...

PROCEPT BioRobotics shows strong revenue growth and expanding market presence but struggles with profitability and rising operational costs. The company’s HYDROS robotic system and consumables ...

PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.35 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.54 per share a year ago. These ...

Analysts' ratings for PROCEPT BioRobotics PRCT over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a concise overview of recent ratings by ...

Procept Biorobotics Corp (PRCT) reported its fourth-quarter 2024 earnings, revealing a revenue of $68.24 million, surpassing the forecast of $66.83 million. Despite the revenue beat, the company ...